Reporte zur Charge U36B21A

Symptomtext

pain in bottoms left side and pain in both shoulders; pain in arms when lifting up arm and pain in both shoulder; Pain in bottoms left side; This spontaneous case was reported by a consumer and describes the occurrence of ARTHRALGIA (pain in bottoms left side and pain in both shoulders), MYALGIA (pain in arms when lifting up arm and pain in both shoulder) and MUSCULOSKELETAL PAIN (Pain in bottoms left side) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. U36B21A and 022C21A) for COVID-19 vaccination. No medical history was provided by the reporter. Concomitant products included LISINOPRIL, METOPROLOL, AMLODIPINE and ROSUVASTATIN for an unknown indication. On 29-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 10-May-2021, the patient experienced MUSCULOSKELETAL PAIN (Pain in bottoms left side). On an unknown date, the patient experienced ARTHRALGIA (pain in bottoms left side and pain in both shoulders) and MYALGIA (pain in arms when lifting up arm and pain in both shoulder). The patient was treated with PARACETAMOL (TYLENOL) ongoing since an unknown date at an unspecified dose and frequency; IBUPROFEN ongoing since an unknown date at an unspecified dose and frequency; NAPROXEN SODIUM (ALEVE) ongoing since an unknown date at an unspecified dose and frequency and MELOXICAM (oral) ongoing since an unknown date at a dose of 7.5 mg. At the time of the report, ARTHRALGIA (pain in bottoms left side and pain in both shoulders), MYALGIA (pain in arms when lifting up arm and pain in both shoulder) and MUSCULOSKELETAL PAIN (Pain in bottoms left side) had not resolved. Concomitant medications included hydrochloro as reported by the reporter. Most recent FOLLOW-UP information incorporated above includes: On 09-Jun-2021: TCR received on 9-JUN-2021 contains no new information. On 14-Jun-2021: Follow up received on 14-JUN-2021 contains Meloxicam 7.5 mg as new treatment drug